Yüksel Ürün
@yukselurun.bsky.social
Medical Oncologist 🔬 @AnkaraUni 🎓 Advocate for #Diversity & #Equity 🌟 Genitourinary Cancer
Immunotherapy Rechallenge in Metastatic Renal Cell Carcinoma - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma
Yüksel Ürün: Immunotherapy Rechallenge in Metastatic Renal Cell Carcinoma - OncoDaily
Yüksel Ürün: Immunotherapy Rechallenge in Metastatic Renal Cell Carcinoma / Bradley A. McGregor, cancer, Emre Yekedüz, Hatice Bölek, OncoDaily, Oncology, Rana
oncodaily.com
High Response in cSCC but Significant Rejection Risk With Checkpoint Drugs - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Yüksel Ürün: High Response in cSCC but Significant Rejection Risk With Checkpoint Drugs - OncoDaily
Yüksel Ürün: High Response in cSCC but Significant Rejection Risk With Checkpoint Drugs / Anh Kieu, Annabelle Wilson, Armando Teixeira-Pinto, Billie Bonevski,
oncodaily.com
Urinary Diversion After Cystectomy for Bladder Cancer @oncoalert.bsky.social @jama.com doi:10.1001/jamaoncol.2025.3644
Biz doktor değiliz sadece. Birine iyi gelme niyeti taşıyan insanlarız…
ASCO LDP is One of ASCO’s Best - Yüksel Ürün @yukselurun.bsky.social @ascocancer.bsky.social oncodaily.com/voices/asco-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Yüksel Ürün: ASCO LDP is One of ASCO’s Best - OncoDaily
Yüksel Ürün: ASCO LDP is One of ASCO’s Best / ASCO, ASCO LDP, cancer, Leadership Development Program, OncoDaily, Oncology, Yüksel Ürün
oncodaily.com
ASCO LDP is one of ASCO’s best. Happy and proud to be part of it. Leadership in cancer care is not status, it is service. We grow when we listen, advocate, and walk with others. @ascocancer.bsky.social @oncoalert.bsky.social
Some illnesses touch the body, some touch the quiet place in the soul. Healing often begins there…
The best technology in cancer care is empathy. Without it, even perfect data feels cold…
We talk about survival, Patients talk about life. We must learn patients’ language…
When we treat the disease, we help. When we treat the person, we heal.
📍2025-2029 ISLB President @UmbertoMalapel1 and Vice President @ElJanLe in the Closing Ceremony - Orlando Congress. A lot of work to do to prepare educational activities, workshops, guidelines and our next congress in Madrid 2026. @christianrolfo.bsky.social @islb.info @yukselurun.bsky.social
Three Words, One Mission - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Yüksel Ürün: Three Words, One Mission - OncoDaily
Yüksel Ürün: Three Words, One Mission / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, OncoDaily, Oncology, Yüksel Ürün
oncodaily.com
Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC - Yüksel Ürün @yukselurun.bsky.social @erikahamilton9.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Yüksel Ürün: Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC - OncoDaily
Yüksel Ürün: Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC / cancer, Erika Hamilton, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, OncoDaily,
oncodaily.com
Global Cancer Burden Calls for Action on Prevention and Equity - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity - OncoDaily
Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity / cancer, OncoDaily, Oncology, Yüksel Ürün
oncodaily.com
Proud to join such inspiring colleagues as an #ESMOAmbassadors Excited for #ESMO25 and all the new #CancerResearch ahead. @myesmo.bsky.social
ESMO - European Society for Medical Oncology@myesmo.bsky.social · 11mo ago@ptarantinomd.bsky.social ; @yukselurun.bsky.social ; @arndtvogel.bsky.social ; @tiansterzhangmd.bsky.social
Hastalarımıza gerçeği anlatmak. Ne korku satmak, ne de sahte umut vermek. Medya, veriyi dürüst anlattığında güç katar. Ama çarpıtılmış grafikler, abartılmış başlıklar, seçilmiş veriler… Korku yaratır. Umudu kirletir. Gerçeği savunmak, hastalarımızı korumaktır. Veri konuşsun, biz dinleyelim.
Cancer care often forgets those at the edges: teens, elders, people with rare cancers. Their needs don’t fit the standard path. Fertility, intimacy, body image deserve the same care as the tumor. @oncoalert.bsky.social @oncoassist.bsky.social
Every patient is first a human being with a name, a story, a dream. Dignity is part of the treatment. Never reduce a life to a diagnosis… @ascocancer.bsky.social @myesmo.bsky.social @oncoalert.bsky.social
Proud of our rising star Coşkun and all colleagues. This meta-analysis on PARP inhibitors and thrombosis risk asks the right question for patients. @oncoalert.bsky.social @myesmo.bsky.social @apccc.bsky.social @drchoueiri.bsky.social @neerajagarwal.bsky.social
“Medice, cura te ipsum” Doctor, heal yourself. Even healers burn out. Rest is not weakness, it is repair. Caring for others starts with caring for yourself. @oncoalert.bsky.social @oncbrothers.bsky.social @ascocancer.bsky.social @myesmo.bsky.social
Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting @yukselurun.bsky.social oncodaily.com/pulse/dr-yuk... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #VIRO #VIRO25
Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting - OncoDaily
Dr. Yüksel Ürün at VIRO 2025 shares insights on personalizing frontline kidney cancer treatment, emphasizing biology and patient-centered care.
oncodaily.com
Join Us for Global Voices in Renal Oncology Virtual Congress 2025 @yukselurun.bsky.social oncodaily.com/pulse/global... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Global voices, shared hope. Excited to join colleagues at VIRO 2025—working together for patients in renal cancer. #OncoDaily #VIRO2025 @oncodaily.bsky.social docs.google.com/forms/d/e/1F...
🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay & co-chaired by Dr. Yüksel Ürün @yukselurun.bsky.social 🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲: forms.gle/qcQyaGMQfHDh... oncodaily.com/pulse/rana-m... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd
Meet the Experts of VIRO 2025 - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/pulse/yuksel... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Yüksel Ürün: Meet the Experts of VIRO 2025
Prof. Yüksel Ürün is a distinguished Professor of Medical Oncology at Ankara University School of Medicine and one of Turkey’s leading experts in
oncodaily.com
Liquid Biopsy Is No Longer the Future - Yüksel Ürün @yukselurun.bsky.social @neerajagarwal.bsky.social @euplatinum.bsky.social oncodaily.com/science/liqu... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LiquidBiopsy
Yüksel Ürün: Liquid Biopsy Is No Longer the Future - OncoDaily
Yüksel Ürün: Liquid Biopsy Is No Longer the Future / Antonio Alcaraz, Benjamin L Maughan, cancer, Emmanuel S Antonarakis, genitourinary malignancies, Lars
oncodaily.com
